CIRCULOGENE
J. Kevin Day, PhD, HCLD (ABB) is currently serving as the Vice President of Laboratory Operations at CIRCULOGENE. Prior to this, J. Kevin held similar positions at Metabolon, Inc. and Inivata. Day has a diverse background in laboratory operations, with experience at companies like Foundation Medicine, Sequenom Laboratories, and Sorenson Genomics. J. Kevin also has a strong history of involvement in community groups and non-profit organizations, serving in various roles such as Assistant District Commissioner and President. Day has a strong educational background, holding a PhD in Genetics and Biochemistry from the University of Missouri-Columbia, as well as master's and bachelor's degrees in Molecular Biology from Brigham Young University.
This person is not in any offices
CIRCULOGENE
Applying its proprietary laboratory developed test for cfDNA, cfRNA and MSI liquid biopsies, CIRCULOGENE has developed a next-generation sequencing (NGS) method to provide full genomic load analysis from one standard tube of blood in one week, enabling more accurate data to help clinicians and their patients choose targeted therapies, monitor efficacy and monitor for recurrence.